# Bassett Furniture Industries Inc: financial statements, quarterly

BSET · Nasdaq · CIK 10329 · [Materials](/sectors/materials.md) · fiscal year ends Nov 28

Pages: [Overview](/companies/bset.md) · [Financials](/companies/bset/financials.md) · [Filings](/companies/bset/filings.md) · [Insiders](/companies/bset/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bset/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-25) | Q1 FY2024 (2024-03-02) | Q2 FY2024 (2024-06-01) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-03-01) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-30) | Q4 FY2025 (2025-11-29) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-30) | Q3 FY2026 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [94.7 d](/filings/0001437749-26-003189.md) | [86.6](/filings/0001437749-25-010822.md) | [83.4](/filings/0001437749-25-022483.md) | [75.6](/filings/0001437749-25-030703.md) | [84.3 d](/filings/0001437749-26-003189.md) | [82.2](/filings/0001437749-26-010901.md) | [84.3](/filings/0001437749-26-022289.md) | [80.1](/filings/0001437749-26-031602.md) | [88.7 d](/filings/0001437749-26-003189.md) | [80.3](/filings/0001437749-26-010901.md) | [83.8](/filings/0001437749-26-022289.md) | [82.8](/filings/0001437749-26-031602.md) |
| Cost of revenue | $m | [43.3 d](/filings/0001437749-26-003189.md) | [38.7](/filings/0001437749-25-010822.md) | [39.7](/filings/0001437749-25-022483.md) | [35.5](/filings/0001437749-25-030703.md) | [36.6 d](/filings/0001437749-26-003189.md) | [35.3](/filings/0001437749-26-010901.md) | [37.4](/filings/0001437749-26-022289.md) | [35.1](/filings/0001437749-26-031602.md) | [38.7 d](/filings/0001437749-26-003189.md) | [35.2](/filings/0001437749-26-010901.md) | [36.4](/filings/0001437749-26-022289.md) | [35.2](/filings/0001437749-26-031602.md) |
| Gross profit | $m | [51.4 d](/filings/0001437749-26-003189.md) | [47.9](/filings/0001437749-25-010822.md) | [43.8](/filings/0001437749-25-022483.md) | [40.1](/filings/0001437749-25-030703.md) | [47.7 d](/filings/0001437749-26-003189.md) | [46.8](/filings/0001437749-26-010901.md) | [46.9](/filings/0001437749-26-022289.md) | [45.0](/filings/0001437749-26-031602.md) | [49.9 d](/filings/0001437749-26-003189.md) | [45.2](/filings/0001437749-26-010901.md) | [47.3](/filings/0001437749-26-022289.md) | [47.6](/filings/0001437749-26-031602.md) |
| Selling, general and administrative | $m | [50.5 d](/filings/0001437749-26-003189.md) | [50.2](/filings/0001437749-25-010822.md) | [46.7](/filings/0001437749-25-022483.md) | [45.2](/filings/0001437749-25-030703.md) | [45.4 d](/filings/0001437749-26-003189.md) | [44.4](/filings/0001437749-26-010901.md) | [44.4](/filings/0001437749-26-022289.md) | [44.4](/filings/0001437749-26-031602.md) | [47.2 d](/filings/0001437749-26-003189.md) | [43.9](/filings/0001437749-26-010901.md) | [44.6](/filings/0001437749-26-022289.md) | [44.7](/filings/0001437749-26-031602.md) |
| Operating income | $m | [(4.5) d](/filings/0001437749-26-003189.md) | [(2.4)](/filings/0001437749-25-010822.md) | [(8.5)](/filings/0001437749-25-022483.md) | [(6.4)](/filings/0001437749-25-030703.md) | [0.9 d](/filings/0001437749-26-003189.md) | [2.5](/filings/0001437749-26-010901.md) | [2.5](/filings/0001437749-26-022289.md) | [0.6](/filings/0001437749-26-031602.md) | [2.3 d](/filings/0001437749-26-003189.md) | [1.2](/filings/0001437749-26-010901.md) | [2.2](/filings/0001437749-26-022289.md) | [2.8](/filings/0001437749-26-031602.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.0) d](/filings/0001437749-26-003189.md) | [(0.5)](/filings/0001437749-25-010822.md) | [(0.9)](/filings/0001437749-25-022483.md) | [(1.3)](/filings/0001437749-25-030703.md) | [(2.0) d](/filings/0001437749-26-003189.md) | [0.7](/filings/0001437749-26-010901.md) | [0.7](/filings/0001437749-26-022289.md) | [0.3](/filings/0001437749-26-031602.md) | [1.0 d](/filings/0001437749-26-003189.md) | [0.4](/filings/0001437749-26-010901.md) | [0.7](/filings/0001437749-26-022289.md) | [0.8](/filings/0001437749-26-031602.md) |
| Net income | $m | [(4.1) d](/filings/0001437749-26-003189.md) | [(1.2)](/filings/0001437749-25-010822.md) | [(7.2)](/filings/0001437749-25-022483.md) | [(4.5)](/filings/0001437749-25-030703.md) | [3.2 d](/filings/0001437749-26-003189.md) | [1.9](/filings/0001437749-26-010901.md) | [1.9](/filings/0001437749-26-022289.md) | [0.8](/filings/0001437749-26-031602.md) | [1.5 d](/filings/0001437749-26-003189.md) | [1.1](/filings/0001437749-26-010901.md) | [2.0](/filings/0001437749-26-022289.md) | [2.1](/filings/0001437749-26-031602.md) |
| Diluted EPS | $ per share | not reported | [(0.14)](/filings/0001437749-25-010822.md) | [(0.82)](/filings/0001437749-25-022483.md) | [(0.52)](/filings/0001437749-25-030703.md) | not reported | [0.21](/filings/0001437749-26-010901.md) | [0.22](/filings/0001437749-26-022289.md) | [0.09](/filings/0001437749-26-031602.md) | not reported | [0.13](/filings/0001437749-26-010901.md) | [0.24](/filings/0001437749-26-022289.md) | [0.24](/filings/0001437749-26-031602.md) |
| Basic EPS | $ per share | not reported | [(0.14)](/filings/0001437749-25-010822.md) | [(0.82)](/filings/0001437749-25-022483.md) | [(0.52)](/filings/0001437749-25-030703.md) | not reported | [0.21](/filings/0001437749-26-010901.md) | [0.22](/filings/0001437749-26-022289.md) | [0.09](/filings/0001437749-26-031602.md) | not reported | [0.13](/filings/0001437749-26-010901.md) | [0.24](/filings/0001437749-26-022289.md) | [0.24](/filings/0001437749-26-031602.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-25) | Q1 FY2024 (2024-03-02) | Q2 FY2024 (2024-06-01) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-03-01) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-30) | FY2025 (2025-11-29) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-30) | Q3 FY2026 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.4](/filings/0001437749-25-003216.md) | [40.6](/filings/0001437749-24-010760.md) | [42.6](/filings/0001437749-24-022523.md) | [38.3](/filings/0001437749-24-031014.md) | [39.6](/filings/0001437749-26-003189.md) | [36.1](/filings/0001437749-25-010822.md) | [39.4](/filings/0001437749-25-022483.md) | [34.4](/filings/0001437749-25-030703.md) | [41.3](/filings/0001437749-26-031602.md) | [33.0](/filings/0001437749-26-010901.md) | [35.9](/filings/0001437749-26-022289.md) | [35.4](/filings/0001437749-26-031602.md) |
| Current assets | $m | [158](/filings/0001437749-25-003216.md) | [150](/filings/0001437749-24-010760.md) | [143](/filings/0001437749-24-022523.md) | [138](/filings/0001437749-24-031014.md) | [142](/filings/0001437749-26-003189.md) | [143](/filings/0001437749-25-010822.md) | [144](/filings/0001437749-25-022483.md) | [141](/filings/0001437749-25-030703.md) | [146](/filings/0001437749-26-031602.md) | [140](/filings/0001437749-26-010901.md) | [138](/filings/0001437749-26-022289.md) | [135](/filings/0001437749-26-031602.md) |
| Total assets | $m | [370](/filings/0001437749-25-003216.md) | [361](/filings/0001437749-24-010760.md) | [345](/filings/0001437749-24-022523.md) | [336](/filings/0001437749-24-031014.md) | [341](/filings/0001437749-26-003189.md) | [336](/filings/0001437749-25-010822.md) | [331](/filings/0001437749-25-022483.md) | [324](/filings/0001437749-25-030703.md) | [324](/filings/0001437749-26-031602.md) | [316](/filings/0001437749-26-010901.md) | [317](/filings/0001437749-26-022289.md) | [312](/filings/0001437749-26-031602.md) |
| Current liabilities | $m | [77.9](/filings/0001437749-25-003216.md) | [73.3](/filings/0001437749-24-010760.md) | [71.0](/filings/0001437749-24-022523.md) | [73.1](/filings/0001437749-24-031014.md) | [73.4](/filings/0001437749-26-003189.md) | [73.7](/filings/0001437749-25-010822.md) | [74.5](/filings/0001437749-25-022483.md) | [73.3](/filings/0001437749-25-030703.md) | [77.0](/filings/0001437749-26-031602.md) | [71.8](/filings/0001437749-26-010901.md) | [70.1](/filings/0001437749-26-022289.md) | [69.4](/filings/0001437749-26-031602.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [183](/filings/0001437749-26-003189.md) | [181](/filings/0001437749-24-010760.md) | [172](/filings/0001437749-24-022523.md) | [165](/filings/0001437749-24-031014.md) | [167](/filings/0001437749-26-003189.md) | [167](/filings/0001437749-25-010822.md) | [167](/filings/0001437749-25-022483.md) | [166](/filings/0001437749-25-030703.md) | [165](/filings/0001437749-26-031602.md) | [164](/filings/0001437749-26-010901.md) | [164](/filings/0001437749-26-022289.md) | [165](/filings/0001437749-26-031602.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-25) | Q1 FY2024 (2024-03-02) | Q2 FY2024 (2024-06-01) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-03-01) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-30) | Q4 FY2025 (2025-11-29) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-30) | Q3 FY2026 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [8,475 d](/filings/0001437749-26-003189.md) | [(7,739)](/filings/0001437749-25-010822.md) | [5,820 d](/filings/0001437749-25-022483.md) | [(404) d](/filings/0001437749-25-030703.md) | [6,373 d](/filings/0001437749-26-003189.md) | [(52.0)](/filings/0001437749-26-010901.md) | [6,955 d](/filings/0001437749-26-022289.md) | [(1,177) d](/filings/0001437749-26-031602.md) | [7,765 d](/filings/0001437749-26-003189.md) | [(5,468)](/filings/0001437749-26-010901.md) | [7,364 d](/filings/0001437749-26-022289.md) | [6,117 d](/filings/0001437749-26-031602.md) |
| Capital expenditure | $k | [2,832 d](/filings/0001437749-26-003189.md) | [2,076](/filings/0001437749-25-010822.md) | [1,607 d](/filings/0001437749-25-022483.md) | [1,037 d](/filings/0001437749-25-030703.md) | [491 d](/filings/0001437749-26-003189.md) | [871](/filings/0001437749-26-010901.md) | [1,404 d](/filings/0001437749-26-022289.md) | [1,462 d](/filings/0001437749-26-031602.md) | [793 d](/filings/0001437749-26-003189.md) | [863](/filings/0001437749-26-010901.md) | [1,729 d](/filings/0001437749-26-022289.md) | [4,283 d](/filings/0001437749-26-031602.md) |
| Dividends paid | $k | [1,576 d](/filings/0001437749-26-003189.md) | [1,573](/filings/0001437749-25-010822.md) | [1,580 d](/filings/0001437749-25-022483.md) | [1,756 d](/filings/0001437749-25-030703.md) | [1,745 d](/filings/0001437749-26-003189.md) | [1,734](/filings/0001437749-26-010901.md) | [1,742 d](/filings/0001437749-26-022289.md) | [1,734 d](/filings/0001437749-26-031602.md) | [1,729 d](/filings/0001437749-26-003189.md) | [1,730](/filings/0001437749-26-010901.md) | [1,713 d](/filings/0001437749-26-022289.md) | [1,736 d](/filings/0001437749-26-031602.md) |
| Share repurchases | $k | [120 d](/filings/0001437749-26-003189.md) | [0.0](/filings/0001437749-25-010822.md) | [489 d](/filings/0001437749-25-022483.md) | [638 d](/filings/0001437749-25-030703.md) | [293 d](/filings/0001437749-26-003189.md) | [721](/filings/0001437749-26-010901.md) | [437 d](/filings/0001437749-26-022289.md) | [364 d](/filings/0001437749-26-031602.md) | [628 d](/filings/0001437749-26-003189.md) | [147](/filings/0001437749-26-010901.md) | [506 d](/filings/0001437749-26-022289.md) | [126 d](/filings/0001437749-26-031602.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-02-25) | Q2 FY2023 (2023-05-27) | Q3 FY2023 (2023-08-26) | Q1 FY2024 (2024-03-02) | Q2 FY2024 (2024-06-01) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-03-01) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-30) | Q3 FY2026 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,897](/filings/0001437749-24-010760.md) | [8,822](/filings/0001437749-24-022523.md) | [8,736](/filings/0001437749-24-031014.md) | [8,741](/filings/0001437749-25-010822.md) | [8,763](/filings/0001437749-25-022483.md) | [8,725](/filings/0001437749-25-030703.md) | [8,706](/filings/0001437749-26-010901.md) | [8,680](/filings/0001437749-26-022289.md) | [8,675](/filings/0001437749-26-031602.md) | [8,652](/filings/0001437749-26-010901.md) | [8,636](/filings/0001437749-26-022289.md) | [8,639](/filings/0001437749-26-031602.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,651,361 at 2026-09-24, from the cover of the [10-Q filed 2026-09-30](/filings/0001437749-26-031602.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.